newsfilter
← Latest News
GlobeNewswire·

Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome

-First ever IND submission for this disease, which has no current treatment or cure- -Quoin plans Phase 2 study initiation in 2H 2026- -Submission supported by positive initial clinical data from Investigator-led